Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for ImmunityBio (IBRX) over the last 12 years, with Q3 2025 value amounting to $4.0 million.

  • ImmunityBio's Depreciation & Amortization (CF) fell 1131.31% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year decrease of 1213.57%. This contributed to the annual value of $17.6 million for FY2024, which is 517.5% down from last year.
  • ImmunityBio's Depreciation & Amortization (CF) amounted to $4.0 million in Q3 2025, which was down 1131.31% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Depreciation & Amortization (CF) peaked at $5.2 million during Q4 2022, and registered a low of $3.0 million during Q1 2021.
  • For the 5-year period, ImmunityBio's Depreciation & Amortization (CF) averaged around $4.2 million, with its median value being $4.4 million (2024).
  • Per our database at Business Quant, ImmunityBio's Depreciation & Amortization (CF) skyrocketed by 6150.04% in 2021 and then tumbled by 1593.85% in 2025.
  • Quarter analysis of 5 years shows ImmunityBio's Depreciation & Amortization (CF) stood at $3.6 million in 2021, then surged by 45.37% to $5.2 million in 2022, then decreased by 12.67% to $4.6 million in 2023, then decreased by 9.33% to $4.1 million in 2024, then fell by 4.52% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $3.9 million for Q2 2025, and $3.8 million during Q1 2025.